Launching a drug development company with novel technology from academia
Our corporate group has worked with hundreds of entrepreneurs at this stage to help them optimally and efficiently select and form the appropriate legal entity
Linda DeGraw
Director, Contracts Specialist
Linda has dedicated more than twenty-five years to drafting, negotiating and managing specialized contracts in the biopharmaceutical industry.
Her vast experience includes agreements for preclinical and clinical studies, research collaborations, master services and consulting, and other agreements relating to the development, manufacturing and testing of drug compounds and medical devices, and advice regarding contract management for clinical studies. Linda contributes a valuable expertise to Faber, by focusing much of her work on agreements for large multi-center international clinical studies.
More about Linda
Consultant to Legal Division
Warner Chilcott (now Allergan)
- Drafted and negotiated various agreements relating to the pharmaceutical industry
Manager, Pharmaceutical Licensing & Business Development
Warner-Lambert Company (now Pfizer)
- Evaluated licensing opportunities
- Assisted in structuring business deals
Legal Advisor, Corporate Legal Division
- Responsible for a broad range of agreements relating to research and drug development activities
- Multiple clinical trials sponsored by IDEAYA Biosciences, Inc., including multinational phase 2/3 trials involving sites in North America, Europe and APAC
- Multiple clinical trials sponsored by Zenas Biopharma (USA) LLC, including multinational phase 3 trials involving sites in North America, South America, Europe and Asia
- Phase 2/3 gene therapy clinical trial sponsored by bluebird bio, Inc., involving approximately 12 subjects across 5 sites in Europe and the US
- Multiple clinical trials sponsored by BeiGene, including a multinational phase 3 trial involving approximately 467 subjects across 150 sites in 20 countries located in Asia, Australia, Europe, Canada and the US
- Multiple clinical trials sponsored by Tesaro, Inc., including a multinational phase 3 trial involving approximately 960 subjects across 225 sites in 25 countries located in Asia, Europe, Canada and the US
- Life Science Law Professionals, member
- Model Agreements & Guidelines International (MAGI), member
- Women in the Enterprise of Science & Technology (WEST), member
Consultant to Legal Division
Warner Chilcott (now Allergan)
- Drafted and negotiated various agreements relating to the pharmaceutical industry
Manager, Pharmaceutical Licensing & Business Development
Warner-Lambert Company (now Pfizer)
- Evaluated licensing opportunities
- Assisted in structuring business deals
Legal Advisor, Corporate Legal Division
- Responsible for a broad range of agreements relating to research and drug development activities
- Multiple clinical trials sponsored by IDEAYA Biosciences, Inc., including multinational phase 2/3 trials involving sites in North America, Europe and APAC
- Multiple clinical trials sponsored by Zenas Biopharma (USA) LLC, including multinational phase 3 trials involving sites in North America, South America, Europe and Asia
- Phase 2/3 gene therapy clinical trial sponsored by bluebird bio, Inc., involving approximately 12 subjects across 5 sites in Europe and the US
- Multiple clinical trials sponsored by BeiGene, including a multinational phase 3 trial involving approximately 467 subjects across 150 sites in 20 countries located in Asia, Australia, Europe, Canada and the US
- Multiple clinical trials sponsored by Tesaro, Inc., including a multinational phase 3 trial involving approximately 960 subjects across 225 sites in 25 countries located in Asia, Europe, Canada and the US
- Life Science Law Professionals, member
- Model Agreements & Guidelines International (MAGI), member
- Women in the Enterprise of Science & Technology (WEST), member
Interested in working with Linda?
Our team is eager to learn more about your project